Literature DB >> 31265880

Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.

Sheeraz Un Nazir1, Ramesh Kumar2, Ankita Singh3, Asiya Khan4, Pranay Tanwar4, Richa Tripathi5, Ravi Mehrotra5, Showket Hussain6.   

Abstract

Ets-1 is one of the crucial member of transcription factor family which share a unique DNA binding domain. It is predominantly expressed in various tumor subtypes and has shown its association in the regulation of various important genes which include ECM-degrading proteases. Our study aimed to understand the mechanism(s) in the pathogenesis of breast carcinogenesis by Ets-1 transcription factor and its downstream target gene MMP-9. Role of Ets-1 in MCF-7 and MDA-MB-231 breast cancer cells was studied by RNA-interference in combination with pull down and ChIP assays to identify the regulation of MMP-9 in these cell lines. Our results showed that transfection of Ets-1 siRNA in breast cancer cell lines resulted in downregulation of Ets-1 and MMP-9. Ets-1 knock down also showed reduced cell invasion and altered expression of EMT markers. Moreover, we could also predict that MMP-9 gene promoter harbors a binding site for Ets-1 transcription factor may be responsible in direct transactivation of Ets-1 along with EMT markers. Phenotypic changes and molecular alterations that may result in increased aggressiveness/invasiveness and metastatic nature of cancerous cells may lead to changes in EMT markers. Therefore, these findings may suggest a plausible role of Ets-1 dependent regulation of MMP-9 gene and may have a significant impact on breast carcinogenesis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31265880     DOI: 10.1016/j.gene.2019.143952

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  22 in total

1.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

Review 2.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

3.  lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516.

Authors:  Zhuo Wang; Ruqing Xu
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

4.  Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer.

Authors:  Sunil Kumar Surapaneni; Ebony Nottingham; Arindam Mondal; Nilkumar Patel; Peggy Arthur; Aragaw Gebeyehu; Anil Kumar Kalvala; Arun K Rishi; Mandip Singh
Journal:  Anticancer Res       Date:  2021-09-01       Impact factor: 2.480

5.  Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.

Authors:  Chia-Lung Tsai; Shih-Ming Jung; Lang-Ming Chi; Chi-Neu Tsai; Chiao-Yun Lin; Angel Chao; Yun-Shien Lee
Journal:  Aging (Albany NY)       Date:  2021-05-23       Impact factor: 5.682

Review 6.  The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.

Authors:  Giovanni Barillari
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

7.  ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.

Authors:  Gi-Cheon Kim; Choong-Gu Lee; Ravi Verma; Dipayan Rudra; Taemook Kim; Keunsoo Kang; Jong Hee Nam; Young Kim; Sin-Hyeog Im; Ho-Keun Kwon
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

8.  ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.

Authors:  Tianbo Xu; Hailong Ruan; Su Gao; Jingchong Liu; Yuenan Liu; Zhengshuai Song; Qi Cao; Keshan Wang; Lin Bao; Di Liu; Junwei Tong; Jian Shi; Huageng Liang; Hongmei Yang; Ke Chen; Xiaoping Zhang
Journal:  Aging (Albany NY)       Date:  2020-01-30       Impact factor: 5.682

Review 9.  Immune System Effects on Breast Cancer.

Authors:  Jensen N Amens; Gökhan Bahçecioglu; Pinar Zorlutuna
Journal:  Cell Mol Bioeng       Date:  2021-06-03       Impact factor: 3.337

10.  Long Noncoding RNA SNHG6 Functions as an Oncogene in Non-Small Cell Lung Cancer via Modulating ETS1 Signaling.

Authors:  Hua Geng; Shixiong Li; Meilin Xu
Journal:  Onco Targets Ther       Date:  2020-01-30       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.